Everything you need to know
21 CFR Part 11 is the FDA regulation establishing criteria for electronic records and electronic signatures. It applies to any FDA-regulated organization — pharma, biotech, medical devices, food & beverage — that uses electronic systems for GxP-regulated processes including manufacturing batch records, clinical trial data, quality management, and regulatory submissions.
Opkey auto-generates Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) test scripts directly from your ERP system configurations. Instead of manually authoring thousands of pages of validation protocols, Opkey creates executable IQ/OQ/PQ scripts, runs them with full traceability, and produces GAMP 5-aligned documentation — cutting CSV cycles by 50% or more.
Yes. Opkey's approach aligns with GAMP 5 (ISPE Good Automated Manufacturing Practice) guidelines for risk-based validation. Software categories 3, 4, and 5 each get appropriate validation depth — from standard configuration verification for Category 3 COTS software to comprehensive IQ/OQ/PQ for Category 5 custom applications.
This is Opkey's key differentiator for GxP environments. Self-healing tests automatically adapt when Oracle, Workday, or UKG push updates. Argus AI performs change impact analysis to identify which IQ/OQ/PQ protocols are affected. Your systems stay in a continuously validated state — eliminating costly periodic revalidation that plagues manual CSV programs.
Opkey supports CSV for Oracle Cloud (Fusion), Workday, UKG, SAP, Coupa, ServiceNow, Salesforce, and 15+ enterprise applications. For life sciences specifically, Opkey integrates with Veeva Vault, TrackWise, and other GxP-critical systems, with 30,000+ pre-built test cases covering standard business processes and predicate rule requirements.
Opkey holds SOC 2 Type II, ISO 27001, GDPR, and HIPAA certifications. The platform is built with AES-256 encryption, role-based access controls with segregation of duties, SSO/SAML 2.0 support, and multi-tenant isolation. Our architecture meets the operational control requirements of 21 CFR Part 11 §11.10 and the electronic signature requirements of §11.50–§11.200.